Skip to main content
Katharine McNeill, MD, Neurology, Bronx, NY

KatharineAnneMcNeillMD

Neurology Bronx, NY

Neurooncology

Assistant Professor, Department of Oncology, Montefiore Medical Center

Dr. McNeill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. McNeill's full profile

Already have an account?

  • Office

    Montefiore Medical Center
    111 E 210th St
    Bronx, NY 10467
    Phone+1 718-920-4057

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 2006 - 2009
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2005 - 2006
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 2005

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2013 - 2026
  • MD State Medical License
    MD State Medical License 2008 - 2015
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Challenges in clinical trial design for recurrent glioblastoma  
    McNeill, KA, Fine, HA, Clinical Investigation, 9/2013
  • Chemoirradiation for glioblastoma multiforme: the national cancer institute experience  
    Ho, J, Ondos, J, Ning, H, Smith, S, Kreisl, T, Iwamoto, F, Kim, L, McNeill, K, Krauze, A, Shankavaram, U, Fine, HA, Camphausen, K, PLoS One, 8/2013
  • A phase I/II trial of vandetanib for patients with recurrent malignant glioma  
    Kreisl, TN, Mcneill KA, Sul J, Iwamoto F, Shih J, Fine HA, Neuro-Oncology, 12/2012

Professional Memberships